4D Molecular Therapeutics, Inc.
FDMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$161 | -$101 | -$107 | -$71 |
| Dep. & Amort. | $7 | $6 | $4 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $26 | $20 | $0 | $14 |
| Change in WC | $1 | $1 | -$1 | -$16 |
| Other Non-Cash | -$7 | -$1 | $18 | $1 |
| Operating Cash Flow | -$135 | -$76 | -$87 | -$69 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$3 | -$12 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $9 |
| Inv. Purchases | -$468 | -$55 | -$153 | -$169 |
| Inv. Sales/Matur. | $169 | $0 | $148 | $5 |
| Other Inv. Act. | $0 | $173 | $0 | -$9 |
| Investing Cash Flow | -$302 | $116 | -$17 | -$173 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $331 | $148 | $3 | $114 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $8 | $0 | $4 |
| Financing Cash Flow | $337 | $157 | $3 | $118 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$100 | $197 | -$101 | -$124 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $249 | $52 | $153 | $277 |
| End Cash | $149 | $249 | $52 | $153 |
| Free Cash Flow | -$138 | -$79 | -$98 | -$78 |